The Journal of thoracic and cardiovascular surgery
The most recent articles from:
J. Thorac. Cardiovasc. Surg.
-
J. Thorac. Cardiovasc. Surg. · Apr 2022
Multicenter StudyPulmonary homograft dysfunction after the Ross procedure using decellularized homografts-a multicenter study.
Pulmonary homograft dysfunction is a limitation after the Ross procedure. Decellularized pulmonary homografts can potentially mitigate this complication. The aim of this study was to examine the incidence, predictors, progression, and morphology of pulmonary homograft dysfunction using data from the Canadian Ross Registry. ⋯ The use of decellularized cryopreserved pulmonary homografts results in a low incidence of dysfunction and reintervention after the Ross procedure. The risk is greater in the first postoperative year. Younger age is the only independent risk factor for pulmonary homograft dysfunction.